Literature DB >> 17298212

Metabolic disorders in patients with chronic kidney failure.

R Cibulka1, J Racek.   

Abstract

This review article summarizes the problems of metabolic disorders and nutrition imbalances that often occur in chronic kidney failure (CKF) or following regular dialysis treatment. In this survey, we cover the pathogenesis of these disorders, their clinical consequences, and their association with the most severe complications of chronic kidney failure and dialysis treatment. These complications are primarily atherosclerosis, malnutrition, anemia, hyperparathyroidism, and other serious problems that markedly and negatively affect prognosis and the quality of life of uremic patients. Risk factors for cardiovascular disease are discussed in-depth because cardiovascular disease is the leading cause of death in patients with chronic kidney failure. It is important to pay attention to the development of these complications because early diagnosis and therapy can improve the prognosis for these patients and reduce treatment costs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17298212

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  14 in total

1.  Twenty classic hand radiographs that lead to diagnosis.

Authors:  Govind B Chavhan; Elka Miller; Erika H Mann; Stephen F Miller
Journal:  Pediatr Radiol       Date:  2010-02-04

2.  Identification of differentially expressed miRNAs associated with chronic kidney disease-mineral bone disorder.

Authors:  Kyung Im Kim; Sohyun Jeong; Nayoung Han; Jung Mi Oh; Kook-Hwan Oh; In-Wha Kim
Journal:  Front Med       Date:  2017-06-14       Impact factor: 4.592

3.  Serum metabolites are associated with all-cause mortality in chronic kidney disease.

Authors:  Jiun-Ruey Hu; Josef Coresh; Lesley A Inker; Andrew S Levey; Zihe Zheng; Casey M Rebholz; Adrienne Tin; Lawrence J Appel; Jingsha Chen; Mark J Sarnak; Morgan E Grams
Journal:  Kidney Int       Date:  2018-06-02       Impact factor: 10.612

4.  Peroxisome proliferator-activated receptor-γ-coactivator 1α (PGC-1α) gene expression in chronic kidney disease patients on hemodialysis: relation to hemodialysis-related cardiovascular morbidity and mortality.

Authors:  Eman Tayae Elsayed; Rasha Adel Nassra; Yasmine Salah Naga
Journal:  Int Urol Nephrol       Date:  2017-05-26       Impact factor: 2.370

Review 5.  Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation.

Authors:  Abhijit Jagdale; David K C Cooper; Hayato Iwase; Robert S Gaston
Journal:  Xenotransplantation       Date:  2018-11-20       Impact factor: 3.907

6.  Association of Plasma Thrombospondin-1 Level with Cardiovascular Disease and Mortality in Hemodialysis Patients.

Authors:  Chi-Lun Huang; Yuh-Shiun Jong; Yen-Wen Wu; Wei-Jie Wang; Ai-Ru Hsieh; Chia-Lun Chao; Wen-Jone Chen; Wei-Shiung Yang
Journal:  Acta Cardiol Sin       Date:  2015-03       Impact factor: 2.672

7.  Analysis of Arterial Blood Gas Report in Chronic Kidney Diseases - Comparison between Bedside and Multistep Systematic Method.

Authors:  Ishita Ghatak; Vaishali Dhat; Mona A Tilak; Indranath Roy
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 8.  Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease.

Authors:  Simona Granata; Alessandra Dalla Gassa; Gloria Bellin; Antonio Lupo; Gianluigi Zaza
Journal:  Biomed Res Int       Date:  2016-06-21       Impact factor: 3.411

9.  Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.

Authors:  Simona Granata; Gianluigi Zaza; Simona Simone; Gaetano Villani; Dominga Latorre; Paola Pontrelli; Massimo Carella; Francesco Paolo Schena; Giuseppe Grandaliano; Giovanni Pertosa
Journal:  BMC Genomics       Date:  2009-08-21       Impact factor: 3.969

10.  A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients.

Authors:  Gianluigi Zaza; Simona Granata; Federica Rascio; Paola Pontrelli; Maria Pia Dell'Oglio; Sharon Natasha Cox; Giovanni Pertosa; Giuseppe Grandaliano; Antonio Lupo
Journal:  BMC Med Genomics       Date:  2013-05-10       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.